ACTA2 and idiopathic pulmonary fibrosis: However, we observed a decreased expression of ACTA2, COL1A1 and FN1 mRNA in three IPF PCLS treated with PRRX1 ASO compared to control ASO-treated ones (Figure 8—figure supplement 1).